AV
AVD.US American Vanguard Corporation
- Market cap
- USD 25.9M
- P/E
- -
- P/B
- 0.16x
- ROE
- -25.9%
- Dividend yield
- 9.70%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is AVD.US undervalued?
Graham numberThe Graham number of American Vanguard Corporation cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
American Vanguard Corporation fundamental analysis
No fundamental analysis for American Vanguard Corporation yet.
American Vanguard Corporation stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About American Vanguard Corporation
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets synthetic, biological, and biorational products for agricultural, commercial, and consumer uses in the United States and internationally. The company synthesizes and formulates chemicals and ferments and extracts microbial products for crops, turf, ornamental plants, and human and animal health protection, such as insecticides, fungicides, herbicides, soil health, plant nutrition, mo…
Full company profileAmerican Vanguard Corporation financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
American Vanguard Corporation annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 312M | 355M | 454M | 468M | 459M | 558M | 610M | 579M | 547M | 515M | 465M |
| Gross Profit | 128M | 147M | 183M | 177M | 173M | 171M | 241M | 179M | 120M | 148M | 133M |
| Operating Income | 20.5M | 26.8M | 39.0M | 26.2M | 22.9M | 30.9M | 40.7M | 23.3M | -102M | 13.8M | -7.52M |
| EBITDA | 36.9M | 43.8M | 57.9M | 44.9M | 43.3M | 57.0M | 62.2M | 44.7M | -9.66M | -11.8M | 8.48M |
| Net Income | 12.8M | 20.3M | 24.2M | 13.6M | 15.2M | 18.6M | 27.4M | 7.52M | -126M | -49.9M | -42.2M |
| EPS | 0.44 | 0.68 | 0.81 | 0.46 | 0.51 | 0.61 | 0.92 | 0.26 | -4.50 | -1.75 | -1.47 |
| Balance Sheet | |||||||||||
| Total Assets | 430M | 536M | 594M | 691M | 680M | 694M | 726M | 768M | 637M | 597M | 663M |
| Total Liabilities | 148M | 230M | 264M | 347M | 320M | 321M | 356M | 398M | 404M | 404M | 500M |
| Shareholders' Equity | 282M | 305M | 329M | 344M | 361M | 373M | 370M | 370M | 233M | 192M | 163M |
| Cash & Short-term Investments | 7.87M | 11.3M | 6.17M | 6.58M | 15.9M | 16.3M | 20.3M | 11.4M | 12.5M | 12.4M | 83.9M |
| Total Debt | 41.0M | 77.5M | 101M | 160M | 120M | 78.1M | 76.2M | 162M | 168M | 191M | 285M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 46.4M | 59.0M | 11.3M | 9.40M | 89.2M | 87.3M | 57.1M | -58.7M | 3.92M | -21.2M | -16.5M |
| Capital Expenditure | 10.9M | 88.6M | 27.7M | 13.0M | 11.2M | 10.0M | 14.6M | 12.1M | 7.69M | 4.08M | 6.23M |
| Free Cash Flow | 35.6M | -29.6M | -16.4M | -3.58M | 77.9M | 77.3M | 42.6M | -70.8M | -3.77M | -25.3M | -22.7M |
| Ratios | |||||||||||
| ROE | 4.5% | 6.6% | 7.3% | 4.0% | 4.2% | 5.0% | 7.4% | 2.0% | -54.2% | -25.9% | -25.9% |
| ROA | 3.0% | 3.8% | 4.1% | 2.0% | 2.2% | 2.7% | 3.8% | 1.0% | -19.8% | -8.4% | -6.4% |
| Net Profit Margin | 4.1% | 5.7% | 5.3% | 2.9% | 3.3% | 3.3% | 4.5% | 1.3% | -23.1% | -9.7% | -9.1% |
| Debt to Equity | 0.15x | 0.25x | 0.31x | 0.47x | 0.33x | 0.21x | 0.21x | 0.44x | 0.72x | 0.99x | 1.74x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
American Vanguard Corporation dividends
- Dividend yield
- 9.70%
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Jun 26, 2024
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 2.51M | 0.09 | - |
| 2024 | USD 2.51M | 0.09 | - |
| 2023 | USD 3.38M | 0.12 | 45.0% |
| 2022 | USD 2.79M | 0.09 | 10.2% |
| 2021 | USD 2.38M | 0.08 | 12.8% |
| 2020 | USD 1.17M | 0.04 | 7.7% |
| 2019 | USD 2.32M | 0.08 | 17.1% |
| 2018 | USD 2.20M | 0.07 | 9.1% |
| 2017 | USD 1.60M | 0.05 | 7.9% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 4:3 on Apr 18, 2006.
Who owns American Vanguard Corporation
- Insiders 6.70%
- Institutions 55.01%
- Public & others 38.29%
- Shares outstanding 29.6M
- Free float 28.4M
Top funds holding AVD.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 797K | 2.70% | 0.00% | Sep 2026 |
| iShares Global Agriculture ETF Comm | 451K | 1.53% | 0.00% | Oct 2026 |
| Fidelity Enhanced Small Cap Core ETF | 303K | 1.03% | +0.27% | Oct 2026 |
| DFA U.S. Small Cap Value I | 170K | 0.58% | -19.97% | Sep 2026 |
| Fidelity Extended Market Index | 143K | 0.49% | +57.77% | Sep 2026 |
| DFA U.S. Small Cap I | 129K | 0.44% | 0.00% | Sep 2026 |
| iShares Micro-Cap ETF | 83.7K | 0.28% | 0.00% | Oct 2026 |
| Fidelity Total Market Index | 50.1K | 0.17% | 0.00% | Sep 2026 |
| EA Bridgeway Omni Small-Cap Value ETF | 48.3K | 0.16% | 0.00% | Oct 2026 |
| Fidelity VIP Disciplined Small Cap Init | 44.7K | 0.15% | 0.00% | Aug 2026 |
| Fidelity Series Total Market Index | 42.1K | 0.14% | 0.00% | Sep 2026 |
| DFA US Micro Cap I | 31.8K | 0.11% | 0.00% | Sep 2026 |
| Invesco RAFI US 1500 Small-Mid ETF | 30.9K | 0.10% | 0.00% | Oct 2026 |
| Dimensional US Small Cap ETF | 28.6K | 0.10% | 0.00% | Oct 2026 |
| Vanguard Growth & Income Inv | 26.7K | 0.09% | -1.48% | Sep 2026 |
| Gabelli Global Mini Mites I | 21.0K | 0.07% | 0.00% | Jun 2026 |
| Goldman Sachs Absolute Ret Trckr Instl | 19.8K | 0.07% | +272.28% | Jun 2026 |
| NVIT Multi-Manager Small Company I | 18.4K | 0.06% | 0.00% | Jan 2026 |
| DFA U.S. Core Equity 1 I | 17.1K | 0.06% | 0.00% | Sep 2026 |
Top institutions holding AVD.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Wellington Management Company LLP | 1.72M | 5.84% | +4.12% | Jun 2026 |
| Vanguard Capital Management, LLC | 1.15M | 3.89% | +0.64% | Jun 2026 |
| BlackRock Inc | 933K | 3.16% | -55.10% | Jun 2026 |
| EVR Research LP | 775K | 2.63% | +7.64% | Jun 2026 |
| Two Sigma Investments LLC | 733K | 2.48% | -1.79% | Jun 2026 |
| Cruiser Capital Advisors, LLC | 572K | 1.94% | 0.00% | Jun 2026 |
| Dimensional Fund Advisors, Inc. | 559K | 1.90% | -27.77% | Sep 2026 |
| D. E. Shaw & Co LP | 530K | 1.80% | +0.00% | Jun 2026 |
| CastleKnight Management LP | 504K | 1.71% | 0.00% | Jun 2026 |
| RBF LLC | 419K | 1.42% | 0.00% | Jun 2026 |
| AQR Capital Management LLC | 373K | 1.26% | +122.55% | Jun 2026 |
| Potomac Capital Management, Inc. | 359K | 1.22% | -42.32% | Jun 2026 |
| Renaissance Technologies Corp | 355K | 1.20% | +62.75% | Jun 2026 |
| American Century Companies Inc | 354K | 1.20% | -20.62% | Jun 2026 |
| Geode Capital Management, LLC | 304K | 1.03% | -54.19% | Jun 2026 |
| FMR Inc | 295K | 1.00% | +9.00% | Jun 2026 |
| Jane Street Group LLC | 292K | 0.99% | 0.00% | Jun 2026 |
| Tudor Investment Corp Et AL | 279K | 0.95% | +38.78% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 210K | 0.71% | -61.56% | Jun 2026 |
| Millennium Management LLC | 203K | 0.69% | 0.00% | Jun 2026 |
American Vanguard Corporation company profile
- Company name
- American Vanguard Corporation
- Ticker
- AVD.US
- Exchange
- USA Stocks
- Listed since
- Jun 22, 1988
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 739
- Fiscal year end
- December
- Address
- 4695 MacArthur Court, Newport Beach, CA, United States, 92660
- Phone
- 949 260 1200
- Website
- american-vanguard.com
About American Vanguard Corporation
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets synthetic, biological, and biorational products for agricultural, commercial, and consumer uses in the United States and internationally. The company synthesizes and formulates chemicals and ferments and extracts microbial products for crops, turf, ornamental plants, and human and animal health protection, such as insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms. It distributes its products through national distribution companies, buying groups, or co-operatives, as well as through sales offices, wholly owned distributors, sales force executives, and sales agents. American Vanguard Corporation was incorporated in 1969 and is headquartered in Newport Beach, California.
American Vanguard Corporation management
10- Mr. Douglas A. Kaye IIIChairman & CEO · born 1969
- Mr. David T. Johnson C.F.A.Chief Accounting Officer · born 1957
- Mr. Timothy J. Donnelly Esq.Chief Information Officer, General Counsel & Secretary · born 1960
- Ms. Shirin KhosraviChief Human Resource Officer · born 1969
- Mr. Shayne M. WetherallChief Executive Officer of Specialty Business · born 1966
- Mr. Matthew HorwathChief Financial Officer · born 1984
- Mr. Jared StanleySenior Vice President of Supply Chain & Operations
- Mr. Anthony Young C.F.A.Director of Investor Relations
- Mr. William A. KuserDirector of Corporate Communications
- Mr. Michael J. DiPaolaChief Commercial Officer